Loading...
Adjuvant Endocrine Therapy in Premenopausal Patients
Endocrine adjuvant therapy is the best-described molecular targeted treatment and should therefore be used for all patients with endocrine-responsive breast cancer. Ta-moxifen for 5 years is standard of care and has proven efficacy in premenopausal patients. The combination of tamoxifen with ovarian...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger GmbH
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931102/ https://ncbi.nlm.nih.gov/pubmed/20824025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156985 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|